About the Event

Breast Update: First Edition!
This event will cover the latest developments in the treatment of breast tumors in the fields of clinical oncology, surgery, and radiation therapy. The main focus will be on the latest news from the San Antonio Breast Cancer Symposium.

There will be 4 sections:

• Hormone-Responsive Cancer: New Developments in 2025
• HER2-Positive Disease: Can Less Be More?
• Triple-Negative Disease: From Biology to Clinical Decision-Making
• Locoregional Treatment and Innovation in Clinical Practice

We will be joined by nationally and regionally renowned speakers in the field of breast cancer, as well as moderators and panelists.

You're our special guest—come join us!

Dr. Renata Cangussu, Dr. Mayana Lopes, and Dr. Gabriela Arruda
Program Coordinators

February 28, 2026, at 7:30 a.m.
Event Timer
00
day(s)
00
hour(s)
00
minute(s)
00
second(s)

WHEN WILL THE EVENT TAKE PLACE?

DATE:

February 28, 2026

SCHEDULE:

7:30 a.m. to 1:00 p.m.

LOCATION:

Novotel Rio Vermelho
Sala Frades
Address: Rua Monte Conselho, 505
Rio Vermelho – ZIP Code 41.940-370 – Salvador, Bahia

TARGET AUDIENCE:

Clinical oncologists, surgical oncologists, breast specialists, radiation oncologists, pathologists, and medical residents.

Confirmed Attendees

Dr. Bruna Zucchetti

Clinical Oncologist – São Paulo, SP | CRM 165827, RQE 86754

Dr. Natália Polidorio

Breast Surgeon – Brasília/DF | CRM 17992, RQE 15448

Dr. Carine Bispo

Clinical Oncologist – Ilhéus, Bahia | CRM 20671, RQE 13109

Dr. Mayana Lopes

Clinical Oncologist – Salvador, Bahia | CRM 20596 RQE 12722

Dr. Gabriela Arruda

Breast Surgeon – Salvador, Bahia | CRM 21523, RQE 12251

Dr. Renata Cangussu

Clinical Oncologist – Salvador, Bahia | CRM 15149, RQE 7528

Dr. Geila Nunez

Clinical Oncologist – Salvador, Bahia | CRM 18146, RQE 10779

Dr. Dyego Nunes

Clinical Oncologist – Salvador, Bahia | CRM 20895, RQE 14873

Dr. Marília Sampaio

Clinical Oncologist – Salvador, Bahia | CRM 25036, RQE 15367

Dr. Maíra Tavares

Clinical Oncologist – Salvador, Bahia | CRM 19598, RQE 11329

Dr. Elisa Saito

Radiation Oncologist – Salvador, Bahia | CRM 14492, RQE 8815

Dr. Jorge Leal

Clinical Oncologist – Salvador, Bahia | CRM 19711, RQE 14563

Dr. Alex Pimenta

Hematologist – Salvador, Bahia | CRM 15979, RQE 5799

Elder Pimenta

Project Management Professional – Salvador, Bahia

Dr. Rafael Batista

Clinical Oncologist – Salvador, Bahia | CRM 19769, RQE 11399

Dr. Vanessa Dybal

Clinical Oncologist – Salvador, Bahia | CRM 15978, RQE 5828

Dr. Sálvia Canguçu

Breast Surgeon – Salvador, Bahia | CRM 17242, RQE 10293

Islania Brandão

Oncology Pharmacist – Salvador, Bahia

Dr. Juliana Orrico

Breast Surgeon – Salvador, Bahia | CRM 17851, RQE 12346

Dr. Cesar Machado

Breast Surgeon – Salvador, Bahia | CRM 15187, RQE 12138

Dr. Patrícia Lopes

Breast Surgeon – Salvador, Bahia | CRM 24977, RQE 15645

Dr. Iris Rabinovich

Breast Surgeon – Curitiba, Paraná | CRM 18548, RQE 13348

Dr. Carine Bispo

Clinical Oncologist – Salvador, Bahia | CRM 20671, RQE 13109

Schedule

7:30 a.m. – Breakfast – Meet the Professor
8:00 a.m. – Welcome and opening remarks – Dr. Gabriela Arruda, Dr. Renata Cangussu, and Dr. Mayana Lopes

Session 1: Hormone-Responsive Disease: New Developments in 2025 | Moderator: Dr. Rafael Batista

08:10 – Adjuvant treatment for HR+ breast cancer: what has really changed in recent years?
Speaker: Dr. Carine Bispo
08:25 – Metastatic Hormone-Receptor-Positive Disease: strategies following progression on CDK4/6 inhibitors
Speaker: Dr. Bruna Zuccheti
08:40 – Lilly: How to optimize care for patients with HR+ / HER2− breast cancer in the adjuvant setting: an integrated and multidisciplinary approach
Speaker: Dr. Mayana Lopes
08:55 – Discussion
Panelists: Dr. Renata Cangussu, Islania Brandão, and Dr. Gabriela Arruda

Session 2: HER2-Positive Cancer: Can Less Be More? | Moderator: Dr. Carine Bispo

9:10 a.m. – Pushing the Boundaries: Antibody-Drug Conjugates (ADCs) in Early-Stage Breast Cancer
Speaker: Dr. Geila Nunez 
09:25 – HER2-Positive Metastatic Disease: Positioning and Sequencing in the Post-T-DXd Era
Speaker: Dr. Dyego Nunes 
09:40 – Discussion
Discussants: Dr. Mayana Lopes and Dr. Gabriela Arruda

9:55 a.m. – Daiichi Satellite Symposium: New Perspectives on the HR+ mBC Landscape Following Progression to Endocrine Therapy
Speaker: Dr. Bruna Zucchetti

10:15 – Coffee Break

10:35 – Novartis Satellite Symposium: Adjuvant Treatment for Breast Cancer: How to Improve Tolerability Without Compromising Efficacy
Speakers: Dr. Marília Sampaio and Dr. Maíra Tavares

Session 3: Triple-Negative Breast Cancer: From Biology to Clinical Decision-Making | Moderator: Dr. Vanessa Dybal

11:05 – ECI: Should we intensify or de-intensify?
Speaker: Dr. Marília Sampaio
11:20 – Metastatic Triple-Negative Breast Cancer: Updates on Therapeutic Sequencing
Speaker: Dr. Maíra Tavares
11:35 – Discussion
Panelists: Dr. Renata Cangussu and Dr. Mayana Lopes

Session 4: Locoregional Treatment and Innovation in Clinical Practice | Moderator: Dr. Sálvia Canguçu

11:50 – Axillary Management in 2026: Is “Less Is Still More” After San Antonio 2025?
Speaker: Dr. Natália Polidorio
12:05 – How to Choose De-escalation Strategies in Adjuvant Therapy with Safety and Clinical Applicability – Radiation Therapy vs. Hormone Therapy
Speakers: Dr. Elisa Saito and Dr. Jorge Leal
12:25 – Discussion
Panelists: Dr. Juliana Orrico, Dr. Cesar Machado, and Dr. Patrícia Lopes

12:45 – Practical use of Artificial Intelligence tools in the oncologist’s daily practice
Speakers: Dr. Alex Pimenta and Elder Pimenta

1:00 p.m. – Closing Remarks: Dr. Renata Cangussu, Dr. Mayana Lopes, and Dr. Gabriela Arruda
Lunch will be served at the hotel restaurant

Diamond Sponsor

Gold Sponsor

Silver Sponsor

Novotel Rio Vermelho | Address: Rua Monte Conselho, 505 – Rio Vermelho – ZIP Code: 41.940-370 – Salvador, Bahia.

Achievement